JAKinib safety takeaways - avoid in older population 65 yo, malignancy, CV risk, VTE risk - appropriate in younger pts w
Tweet Content
JAKinib safety takeaways
- avoid in older population 65 yo, malignancy, CV risk, VTE risk
- appropriate in younger pts without VTE/CVD risk factors
#RNL2023 @RheumNow https://t.co/mFvvqJ9Jbp https://t.co/A76tR2S1Rb
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off